$IMV

IMV Inc

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

PRICE

$0.6753 -

Delayed Price

VOLUME

286

DAY RANGE

- 0.6753

52 WEEK

0.5621 - 2.41

Join Discuss about IMV with like-minded investors

KI
@Kirill_83 #StockTraders.NET
recently

IMV trying to push above vwap

106 Replies 14 πŸ‘ 10 πŸ”₯

profile
@dros #droscrew
recently

+Initiations 7/23: $ACRS $AGFY $AHH $AIZ $CALX $CERT $IMV $INDI $INSE $IS $KERN $MP $OGN $PLL $PLUG $THRY $XXII

131 Replies 15 πŸ‘ 12 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$IMV bidder spotted

150 Replies 8 πŸ‘ 8 πŸ”₯

profile
@Benlax #droscrew
recently

"This is a slight detour from your guys’ pts but this is why the β€œinvest intl for growth” is a failed narrative imv Investing in FM, EM, and most DM-exUS is a bet on banks and resource extraction (aka bad bets mostly) The real growth in the β€œonce they emerge from FM->EM” is almost entirely in consumer disc and tech - and those are mostly captured by US firms. So want to bet on the growth of south korea etc you buy nike and visa amzn and thats obv not reflected in those geo indices"

89 Replies 7 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

scooping some $IMV

117 Replies 7 πŸ‘ 11 πŸ”₯

ES
@Esdrasack #StockTraders.NET
recently

$IMV done with it

42 Replies 8 πŸ‘ 8 πŸ”₯

ES
@Esdrasack #StockTraders.NET
recently

$IMV giving it up covering more

147 Replies 13 πŸ‘ 11 πŸ”₯

ES
@Esdrasack #StockTraders.NET
recently

$IMV coverin some

42 Replies 14 πŸ‘ 9 πŸ”₯

ES
@Esdrasack #StockTraders.NET
recently

back on ss $IMV risk 6.04

126 Replies 6 πŸ‘ 6 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

covred $IMV

116 Replies 11 πŸ‘ 6 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$IMV come to papa

70 Replies 9 πŸ‘ 15 πŸ”₯

GO
@GOUAGHOU #StockTraders.NET
recently

Thanks for calling IMV. halted down. short from 6.7

71 Replies 15 πŸ‘ 7 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

IMV halted on the way down

139 Replies 13 πŸ‘ 11 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

covered $IMV

108 Replies 9 πŸ‘ 10 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

Done with $IMV for now

75 Replies 14 πŸ‘ 10 πŸ”₯

BR
@brAli #StockTraders.NET
recently

$IMV nice move PM

78 Replies 6 πŸ‘ 8 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

will most deff look to ss $IMV at open if it spikes with good volume

145 Replies 7 πŸ‘ 13 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

located some if $IMV

124 Replies 14 πŸ‘ 13 πŸ”₯

profile
@TraderXx #StockTraders.NET
recently

$IMV is in effect, careful with this one today

86 Replies 11 πŸ‘ 10 πŸ”₯

Key Metrics

Market Cap

55.56 M

Beta

0.95

Avg. Volume

84.28 K

Shares Outstanding

82.27 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-10

Next Dividend Date

Company Information

IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of cancer immunotherapies based on the Company's proprietary delivery platform (DPX). This patented technology leverages a differentiated mechanism of action that generates a targeted and durable immune activation with limited side effects. IMV's lead candidate, Maveropepimut-S, is a T cell-activating immunotherapy that combines the utility of the platform with a novel cancer target: survivin. IMV is currently assessing Maveropepimut-S in advanced ovarian cancer, as well as a combination therapy in multiple clinical studies with Merck. IMV is also developing a DPX-based vaccine to fight against COVID-19. Visit www.imv-inc.com and connect with us on Twitter and LinkedIn.

Website:

HQ: ,

Related News